Literature DB >> 20121574

Predicting virologic failure in an HIV clinic.

Gregory K Robbins1, Kristin L Johnson, Yuchiao Chang, Katherine E Jackson, Paul E Sax, James B Meigs, Kenneth A Freedberg.   

Abstract

BACKGROUND: We sought to use data captured in the electronic health record (EHR) to develop and validate a prediction rule for virologic failure among patients being treated for infection with human immunodeficiency virus (HIV).
METHODS: We used EHRs at 2 Boston tertiary care hospitals, Massachusetts General Hospital and Brigham and Women's Hospital, to identify HIV-infected patients who were virologically suppressed (HIV RNA level < or = 400 copies/mL) on antiretroviral therapy (ART) during the period from 1 January 2005 through 31 December 2006. We used a multivariable logistic model with data from Massachusetts General Hospital to derive a 1-year virologic failure prediction rule. The model was validated using data from Brigham and Women's Hospital.We then simplified the scoring scheme to develop a clinical prediction rule.
RESULTS: The 1-year virologic failure prediction model, using data from 712 patients from Massachusetts General Hospital, demonstrated good discrimination (C statistic, 0.78) and calibration (chi(2)= 6.6; P= .58). The validation model, based on 362 patients from Brigham and Women's Hospital, also showed good discrimination (C statistic, 0.79) and calibration (chi(2)= 1.9; P= .93). The clinical prediction rule included 7 predictors (suboptimal adherence, CD4 cell count < 100 cells/microL, drug and/or alcohol abuse, highly ART experienced, missed > or = 1 appointment, prior virologic failure, and suppressed < or = 12 months) and appropriately stratified patients in the validation data set into low-, medium-, and high-risk groups, with 1-year virologic failure rates of 3.0%, 13.0%, and 28.6%, respectively.
CONCLUSIONS: A risk score based on 7 variables available in the EHR predicts HIV virologic failure at 1 year and could be used for targeted interventions to improve outcomes in HIV infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20121574      PMCID: PMC3101804          DOI: 10.1086/650537

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  40 in total

1.  Highly active antiretroviral therapy outcomes in a primary care clinic.

Authors:  D A Rastegar; M I Fingerhood; D R Jasinski
Journal:  AIDS Care       Date:  2003-04

2.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

Authors:  R B D'Agostino; S Grundy; L M Sullivan; P Wilson
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

3.  A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women.

Authors:  Andrea A Howard; Julia H Arnsten; Yungtai Lo; David Vlahov; Josiah D Rich; Paula Schuman; Valerie E Stone; Dawn K Smith; Ellie E Schoenbaum
Journal:  AIDS       Date:  2002-11-08       Impact factor: 4.177

4.  Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.

Authors:  T R Sterling; D Vlahov; J Astemborski; D R Hoover; J B Margolick; T C Quinn
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

5.  Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization.

Authors:  L C Walter; R J Brand; S R Counsell; R M Palmer; C S Landefeld; R H Fortinsky; K E Covinsky
Journal:  JAMA       Date:  2001-06-20       Impact factor: 56.272

6.  Predicting acute renal failure after coronary bypass surgery: cross-validation of two risk-stratification algorithms.

Authors:  E B Fortescue; D W Bates; G M Chertow
Journal:  Kidney Int       Date:  2000-06       Impact factor: 10.612

7.  Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

Authors:  Matthias Egger; Margaret May; Geneviève Chêne; Andrew N Phillips; Bruno Ledergerber; François Dabis; Dominique Costagliola; Antonella D'Arminio Monforte; Frank de Wolf; Peter Reiss; Jens D Lundgren; Amy C Justice; Schlomo Staszewski; Catherine Leport; Robert S Hogg; Caroline A Sabin; M John Gill; Bernd Salzberger; Jonathan A C Sterne
Journal:  Lancet       Date:  2002-07-13       Impact factor: 79.321

8.  How harmful is hazardous alcohol use and abuse in HIV infection: do health care providers know who is at risk?

Authors:  Joseph Conigliaro; Adam J Gordon; Kathleen A McGinnis; Linda Rabeneck; Amy C Justice
Journal:  J Acquir Immune Defic Syndr       Date:  2003-08-01       Impact factor: 3.731

9.  Advances in antiretroviral therapy.

Authors:  Timothy J Wilkin; Barbara Taylor; Susan Olender; Scott M Hammer
Journal:  Top HIV Med       Date:  2009 Apr-May

10.  Virological rebound after suppression on highly active antiretroviral therapy.

Authors:  Amanda Mocroft; Lidia Ruiz; Peter Reiss; Bruno Ledergerber; Christine Katlama; Adriano Lazzarin; Frank-Detlef Goebel; Andrew N Phillips; Bonaventura Clotet; Jens D Lundgren
Journal:  AIDS       Date:  2003-08-15       Impact factor: 4.177

View more
  43 in total

1.  Early retention in HIV care and viral load suppression: implications for a test and treat approach to HIV prevention.

Authors:  Michael J Mugavero; K Rivet Amico; Andrew O Westfall; Heidi M Crane; Anne Zinski; James H Willig; Julia C Dombrowski; Wynne E Norton; James L Raper; Mari M Kitahata; Michael S Saag
Journal:  J Acquir Immune Defic Syndr       Date:  2012-01-01       Impact factor: 3.731

2.  Development and Validation of a Risk Prediction Tool to Identify People with HIV Infection Likely Not to Achieve Viral Suppression.

Authors:  Merhawi T Gebrezgi; Kristopher P Fennie; Diana M Sheehan; Boubakari Ibrahimou; Sandra G Jones; Petra Brock; Robert A Ladner; Mary Jo Trepka
Journal:  AIDS Patient Care STDS       Date:  2020-04       Impact factor: 5.078

3.  The role of at-risk alcohol/drug use and treatment in appointment attendance and virologic suppression among HIV(+) African Americans.

Authors:  Chanelle J Howe; Stephen R Cole; Sonia Napravnik; Jay S Kaufman; Adaora A Adimora; Beth Elston; Joseph J Eron; Michael J Mugavero
Journal:  AIDS Res Hum Retroviruses       Date:  2014-01-20       Impact factor: 2.205

4.  Residential Eviction and Risk of Detectable Plasma HIV-1 RNA Viral Load Among HIV-Positive People Who Use Drugs.

Authors:  Mary Clare Kennedy; Thomas Kerr; Ryan McNeil; Surita Parashar; Julio Montaner; Evan Wood; M-J Milloy
Journal:  AIDS Behav       Date:  2017-03

5.  Changes to antiretroviral drug regimens during integrated TB-HIV treatment: results of the SAPiT trial.

Authors:  Anushka Naidoo; Kogieleum Naidoo; Nonhlanhla Yende-Zuma; Tanuja N Gengiah; Nesri Padayatchi; Andrew L Gray; Sheila Bamber; Gonasagrie Nair; Salim S Abdool Karim
Journal:  Antivir Ther       Date:  2013-10-31

6.  Learning to predict post-hospitalization VTE risk from EHR data.

Authors:  Emily Kawaler; Alexander Cobian; Peggy Peissig; Deanna Cross; Steve Yale; Mark Craven
Journal:  AMIA Annu Symp Proc       Date:  2012-11-03

7.  Treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics across Gauteng and Mpumalanga, South Africa.

Authors:  Denise Evans; Colin Menezes; Kay Mahomed; Philippa Macdonald; Sanlie Untiedt; Leon Levin; Imogen Jaffray; Nainisha Bhana; Cindy Firnhaber; Mhairi Maskew
Journal:  AIDS Res Hum Retroviruses       Date:  2013-02-25       Impact factor: 2.205

8.  [Risk factors associated with virologic failure in HIV- infected patients receiving antiretroviral therapy at a public hospital in Peru].

Authors:  Jorge Alave; Jorge Paz; Elsa González; Miguel Campos; Martin Rodríguez; James Willig; Juan Echevarría
Journal:  Rev Chilena Infectol       Date:  2013-02       Impact factor: 0.520

9.  African American race and HIV virological suppression: beyond disparities in clinic attendance.

Authors:  Chanelle J Howe; Sonia Napravnik; Stephen R Cole; Jay S Kaufman; Adaora A Adimora; Beth Elston; Joseph J Eron; Michael J Mugavero
Journal:  Am J Epidemiol       Date:  2014-05-08       Impact factor: 4.897

10.  Foreign-born status as a predictor of engagement in HIV care in a large US metropolitan health system.

Authors:  Julie H Levison; Susan Regan; Iman Khan; Kenneth A Freedberg
Journal:  AIDS Care       Date:  2016-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.